Refresher Course: Hybrid, Molecular and Translational Imaging

RC 1206 - Hands-on theranostics: focus on prostate cancer diagnostics and treatment

February 28, 08:00 - 09:00 CET

4 min
Chairperson's introduction
Amy Eccles, London / United Kingdom
12 min
Hybrid imaging for prostate cancer staging
Johannes Rübenthaler, Munich / Germany
  1. To learn about the crucial role of PSMA PET in the primary staging of prostate cancer.
  2. To appreciate the limitations of PSMA PET in, e.g. advanced disease.
  3. To understand the principles of hybrid imaging for cancer staging.
12 min
Prerequisites for PSMA therapy: what we need to know and how we find it
James Nagarajah, Nijmegen / Netherlands
  1. To learn about principles of patient selection for PSMA therapy.
  2. To appreciate the role of PSMA therapy in the concept and guidelines for prostate cancer treatment.
  3. To understand the role of imaging in patient selection for PSMA therapy.
12 min
Basics of radioligand therapy: PSMA and beyond
Alexander Walter Sauter, Baden / Switzerland
  1. To learn about the chemical and physical basics of radioligand therapy.
  2. To appreciate the specific challenges and chances of PSMA-targeted therapy.
  3. To understand how targeted therapy can benefit cancer patients
12 min
Monitoring of PSMA-targeted therapy
Maria Picchio, Milan / Italy
  1. To learn about the demand for monitoring of targeted therapy.
  2. To appreciate the challenges and specific imaging findings.
  3. To understand how imaging guides targeted therapy.
8 min
Panel discussion: Chances and challenges of interdisciplinary image-guided therapy